Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

STUART GILMAN'S WEIGHT LOSS PLAN

K-Number: K854441 · 1986-02-10

ApplicantAlpha Therapeutic Corp.
Decision Date1986-02-10
Product CodeLDQ
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

STUART GILMAN'S WEIGHT LOSS PLAN is the device name listed in this FDA 510(k) record. The listed applicant is Alpha Therapeutic Corp.. It received FDA 510(k) clearance on 1986-02-10 under 510(k) number K854441. The device is classified under product code LDQ. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the STUART GILMAN'S WEIGHT LOSS PLAN?

STUART GILMAN'S WEIGHT LOSS PLAN is a medical device that received FDA 510(k) clearance on 1986-02-10. The listed applicant is Alpha Therapeutic Corp.. The 510(k) number is K854441.

When did STUART GILMAN'S WEIGHT LOSS PLAN receive FDA 510(k) clearance?

STUART GILMAN'S WEIGHT LOSS PLAN received FDA 510(k) clearance on 1986-02-10, under 510(k) number K854441.

Who is the listed applicant for STUART GILMAN'S WEIGHT LOSS PLAN?

The FDA 510(k) record lists Alpha Therapeutic Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for STUART GILMAN'S WEIGHT LOSS PLAN?

The FDA product code for STUART GILMAN'S WEIGHT LOSS PLAN is LDQ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Alpha Therapeutic Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K970225ALPHA MICRON 20/40 MICROAGGREGATE FILTERK955515ALPHA MICRON 20 MICROAGGREGATE FILTERK854920THERAPY CASSETTSK833294ALPHA Y-RECIPIENT SETK820447ALPHA PLASMA TRANSFER SETK810897ALPHA PLASTIC PLASMA BOTTLE

View all 8 devices →

Related Devices (Code: LDQ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K993797EC-7701 FLUID WARMING CABINETEnthermics Medical Systems, Inc.K992258HOT SHOT FLUID WARMER IV FLUIDSInfra-Med Technologies, Inc.K981032PIV SYSTEMMedical Solutions, Inc.K973747CONTROLLED TEMPERATURE CABINET SYSTEMSmithK955661ACU-HALTGlederer & Co., Inc.K955776ACU-LABGlederer & Co., Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑